Scinovex
article Open AccessTop 1% cited

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

Gut · 2010 · Vol. 59(9) · pp. 1265–1269
Stuart McPhersonSheila F. StewartElsbeth HendersonAlastair D. BurtChristopher P. Day

Abstract

The ALT/AST ratio, FIB-4 and NAFLD fibrosis scores can reliably exclude advanced fibrosis in a high proportion of patients with NAFLD, allowing liver biopsy to be used in a more directed manner.

Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationLiver Diseases and ImmunityMedicineGastroenterologyInternal medicineSteatohepatitisFatty liverFibrosisLiver biopsyBody mass indexBiopsyDiabetes mellitus

MeSH terms

AdultAlanine TransaminaseAspartate AminotransferasesBiopsyEpidemiologic MethodsFatty LiverFemaleHumansLiver CirrhosisMaleMiddle AgedBiomarkers
Citations
934
FWCI
14.80
field-weighted impact
References
34
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.